$MCET OXIS paid for MCIT achieve particular goals! MultiCell Technologies (MCET) of majority-owned by the subsidiary MultiCell Immunotherapeutics, Inc. (MCIT). content.edgar-online.com/edgar_conv_img/2016/09/26/0001062993-16-011562_EXHIBIT99-1X17X1.JPG content.edgar-online.com/edgar_conv_img/2016/09/26/0001062993-16-011562_EXHIBIT99-1X18X1.JPG